ZA202300128B - A composition for management of covid-19 and associated disorders - Google Patents
A composition for management of covid-19 and associated disordersInfo
- Publication number
- ZA202300128B ZA202300128B ZA2023/00128A ZA202300128A ZA202300128B ZA 202300128 B ZA202300128 B ZA 202300128B ZA 2023/00128 A ZA2023/00128 A ZA 2023/00128A ZA 202300128 A ZA202300128 A ZA 202300128A ZA 202300128 B ZA202300128 B ZA 202300128B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- present disclosure
- covid
- management
- associated disorders
- Prior art date
Links
- 208000025721 COVID-19 Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202021022638 | 2020-05-29 | ||
PCT/IB2021/054727 WO2021240481A2 (en) | 2020-05-29 | 2021-05-29 | A composition for management of covid-19 and associated disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA202300128B true ZA202300128B (en) | 2023-12-20 |
Family
ID=89324813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2023/00128A ZA202300128B (en) | 2020-05-29 | 2023-01-03 | A composition for management of covid-19 and associated disorders |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA202300128B (en) |
-
2023
- 2023-01-03 ZA ZA2023/00128A patent/ZA202300128B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502438A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
BR112014009851A2 (en) | nmda receptor modulators and uses thereof | |
MX2009009623A (en) | Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors. | |
PH12019500208A1 (en) | Spiro-lactam nmda receptor modulators and methods of using same | |
PH12019500202A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
BRPI0918868B8 (en) | nmda receptor modulating compounds and compositions comprising the same | |
PH12019500207A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
MX2019001322A (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof. | |
MX2019001321A (en) | Spiro-lactam nmda receptor modulators and uses thereof. | |
WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
MX2021010058A (en) | Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders. | |
EP2490700A4 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
PH12020551555A1 (en) | Calpain modulators and therapeutic uses thereof | |
MX2020010879A (en) | Bicyclic carboxamides and methods of use thereof. | |
WO2005117940A3 (en) | Cell death modulation via antagonists of fasl and fas activation | |
WO2004093995A3 (en) | Use of antioxidants to treat bone loss disorders | |
MX2020009942A (en) | Compounds and uses thereof. | |
MX2022001952A (en) | Alkynyl quinazoline compounds. | |
ZA202300128B (en) | A composition for management of covid-19 and associated disorders | |
MX2023003675A (en) | Hsd17b13 inhibitors and uses thereof. | |
WO2021240481A3 (en) | A composition for management of covid-19 and associated disorders | |
MX2022005388A (en) | Pyrrolidine and piperidine compounds. | |
SE1750680A1 (en) | Composition for treating or preventing climacteric disorders | |
NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
RU2011113733A (en) | Derivatives of 1-amino-alkylcyclohexane for the treatment of cognitive impairment in noise in the ears |